Volume 65, Issue 2, Pages (February 2004)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk.

Paraneoplastic glomerulopathies: New insights into an old entity

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Stem cells for kidney repair: useful tool for acute renal failure?

Confounding: What it is and how to deal with it

Volume 91, Issue 2, Pages (February 2017)

Prehypertension and chronic kidney disease: the ox or the plow?

Quiz page American Journal of Kidney Diseases

Reassessment of the care of the patient with chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

Sabina Kersting, Leo F. Verdonck

Non-amyloid fibrils in heavy chain deposition disease

The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell.

Volume 58, Issue 1, Pages (July 2000)

New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation Anita D'Souza,

Volume 63, Issue 3, Pages (March 2003)

Metformin and other antidiabetic agents in renal failure patients

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell

Volume 70, Issue 11, Pages (December 2006)

Volume 73, Issue 7, Pages (April 2008)

Alect2 amyloidosis: primum non nocere (first, do no harm)

Sarah A. Holstein, Paul G. Richardson, Jacob P. Laubach, Philip L

Pieter Evenepoel, Björn K. Meijers Kidney International

Volume 70, Issue 12, Pages (December 2006)

Blood pressure targets in hemodialysis patients

Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck

Volume 75, Issue 11, Pages (June 2009)

Volume 85, Issue 3, Pages (March 2014)

Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain Amyloidosis Jason.

The third World Kidney Day: Looking back and thinking forward

Volume 17, Issue 2, Pages (February 1950)

Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant Ahmad Hatem Mattour,

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation Mohammed M. Elayan, Justin G.

Volume 93, Issue 1, Pages (January 2018)

Racial disparities in access to transplantation: a tough nut to crack

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 71, Issue 4, Pages (February 2007)

Antiglomerular basement membrane disease with normal renal function

Evaluation of a Data-Derived Algorithm for Preemptive Use of Plerixafor for Stem Cell Harvest in Patients Eligible for Autologous Stem Cell Transplant.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Alport syndrome: Is diagnosis only skin-deep?

Organ transplantation goes to the movies

Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:

Volume 83, Issue 4, Pages (April 2013)

Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation—A Similar.

Is it the low-protein diet or simply the salt restriction?

Mammen Chandy Biology of Blood and Marrow Transplantation

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 5, Pages (September 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

The international realities of live donor kidney transplantation

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Volume 80, Issue 9, Pages (November 2011)

Development and differentiation of endothelium

Mary Eapen Biology of Blood and Marrow Transplantation

Light of dawn in Melbourne: SONAR and CREDENCE

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

Volume 65, Issue 2, Pages 642-648 (February 2004) High dose chemotherapy in light chain or light and heavy chain deposition disease Bruno Royer, Bertrand Arnulf, Frank Martinez, Lydia Roy, Béatrice Flageul, Isabelle Etienne, Pierre Ronco, Jean-Claude Brouet, Jean- Paul Fermand Kidney International Volume 65, Issue 2, Pages 642-648 (February 2004) DOI: 10.1111/j.1523-1755.2004.00427.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Immunofluorescence study on uninvolved skin of one patient. At diagnosis, deposits of IgG (A), and κ light chain (B) on the elastic fibers at the dermoepidermal junction and around vessels, absence of λ light chain deposits (C). One year after autologous blood stem cell transplant, there is an absence of IgG deposits (D). Kidney International 2004 65, 642-648DOI: (10.1111/j.1523-1755.2004.00427.x) Copyright © 2004 International Society of Nephrology Terms and Conditions